• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

婴儿期溃疡性结肠炎。

Ulcerative colitis in infancy.

机构信息

Department of Paediatric Gastroenterology and Nutrition, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.

出版信息

Saudi J Gastroenterol. 2011 Nov-Dec;17(6):414-7. doi: 10.4103/1319-3767.87185.

DOI:10.4103/1319-3767.87185
PMID:22064342
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3221118/
Abstract

Ulcerative colitis (UC) is a chronic idiopathic inflammatory disorder of colon. Frequency of UC is gradually increasing over few years worldwide. Prevalence is 35 to 100/100,000 people in USA, 1% of them are infants. UC develops in a genetically predisposed individual with altered intestinal immune response. An eight-month-old girl presented with loose bloody stool, growth failure, and moderate pallor. The girl was diagnosed as a case of UC by colonoscopy and biopsy. Treatment was thereafter started with immunosuppressive drugs. After initial induction therapy with parenteral steroid and infliximab, the patient is now on remission with azathioprine and mesalamine. UC is rare in Bangladesh, especially in children, and it is rarer during infancy. Several conditions like infective colitis, allergic colitis, Meckel's diverticulitis, Crohn's disease, etc. may mimic the features of UC. So, if a child presents with recurrent bloody diarrhea, UC should be considered as differential diagnosis.

摘要

溃疡性结肠炎(UC)是一种慢性特发性结肠炎症性疾病。近年来,UC 的发病率在全球范围内呈逐渐上升趋势。在美国,UC 的发病率为 35 至 100/10 万,其中 1%为婴儿。UC 发生于具有肠道免疫反应改变的遗传易感性个体。一名 8 个月大的女孩出现稀便带血、生长发育不良和中度苍白。经结肠镜检查和活检,该女孩被诊断为 UC。此后,开始使用免疫抑制剂进行治疗。经过初始的肠外皮质类固醇和英夫利昔单抗诱导治疗后,患者目前处于缓解状态,使用硫唑嘌呤和美沙拉嗪维持治疗。UC 在孟加拉国很少见,尤其是在儿童中,在婴儿中更为罕见。一些疾病,如感染性结肠炎、过敏性结肠炎、 Meckel 憩室炎、克罗恩病等,可能与 UC 的特征相似。因此,如果儿童出现反复血性腹泻,应考虑将 UC 作为鉴别诊断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a10c/3221118/a634580df81e/SJG-17-414-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a10c/3221118/a634580df81e/SJG-17-414-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a10c/3221118/a634580df81e/SJG-17-414-g001.jpg

相似文献

1
Ulcerative colitis in infancy.婴儿期溃疡性结肠炎。
Saudi J Gastroenterol. 2011 Nov-Dec;17(6):414-7. doi: 10.4103/1319-3767.87185.
2
Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.与溃疡性结肠炎相关的泛发性坏疽性脓皮病:英夫利昔单抗和硫唑嘌呤治疗成功
Acta Dermatovenerol Croat. 2016 Apr;24(1):83-5.
3
Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review.中重度炎症性肠病的常规治疗:系统文献回顾。
World J Gastroenterol. 2019 Mar 7;25(9):1142-1157. doi: 10.3748/wjg.v25.i9.1142.
4
Ulcerative Colitis.溃疡性结肠炎
Digestion. 2016;94(4):181-185. doi: 10.1159/000452621. Epub 2016 Dec 9.
5
Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis.硫唑嘌呤与5-氨基水杨酸治疗激素依赖型溃疡性结肠炎的随机对照试验
Gut. 2006 Jan;55(1):47-53. doi: 10.1136/gut.2005.068809. Epub 2005 Jun 21.
6
Treatment of ulcerative colitis.溃疡性结肠炎的治疗。
Curr Opin Gastroenterol. 2014 Jan;30(1):84-96. doi: 10.1097/MOG.0000000000000031.
7
[Drug therapy of Crohn's disease: slowly increase or start aggressively right away?].[克罗恩病的药物治疗:缓慢增加剂量还是立即积极开始治疗?]
MMW Fortschr Med. 2010 Jan 14;152(1-2):20. doi: 10.1007/BF03365874.
8
Ulcerative colitis.溃疡性结肠炎。
Lancet. 2017 Apr 29;389(10080):1756-1770. doi: 10.1016/S0140-6736(16)32126-2. Epub 2016 Dec 1.
9
[Medical therapy of inflammatory bowel diseases: ulcerative colitis].炎症性肠病的药物治疗:溃疡性结肠炎
Orv Hetil. 2007 Jun 24;148(25):1163-70. doi: 10.1556/OH.2007.28063.
10
Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.通过RAND方法评估炎症性肠病中免疫抑制药物的适用性:意大利炎症性肠病研究小组(IG-IBD)立场声明
Dig Liver Dis. 2005 Jun;37(6):407-17. doi: 10.1016/j.dld.2004.12.013.

引用本文的文献

1
Inflammatory Bowel Disease in Children: Experience and Constraints in a Resource-limited Setting.儿童炎症性肠病:资源有限环境下的经验与限制
Cureus. 2020 Apr 27;12(4):e7848. doi: 10.7759/cureus.7848.
2
Ulcerative colitis in a Nigerian girl: a case report.一名尼日利亚女孩的溃疡性结肠炎:病例报告。
BMC Res Notes. 2012 Oct 10;5:564. doi: 10.1186/1756-0500-5-564.

本文引用的文献

1
Age as a clinical predictor of relapse after induction therapy in ulcerative colitis.年龄作为溃疡性结肠炎诱导治疗后复发的临床预测指标。
Hepatogastroenterology. 2009 Sep-Oct;56(94-95):1304-9.
2
The diagnosis and treatment of Crohn's disease and ulcerative colitis.克罗恩病和溃疡性结肠炎的诊断与治疗。
Dtsch Arztebl Int. 2009 Feb;106(8):123-33. doi: 10.3238/arztebl.2009.0123. Epub 2009 Feb 20.
3
Systematic review: the role of breastfeeding in the development of pediatric inflammatory bowel disease.系统评价:母乳喂养在小儿炎症性肠病发展中的作用
J Pediatr. 2009 Sep;155(3):421-6. doi: 10.1016/j.jpeds.2009.03.017. Epub 2009 May 22.
4
Does inflammatory bowel disease develop in infants?炎症性肠病会在婴儿中发生吗?
Inflamm Bowel Dis. 2008 Oct;14 Suppl 2(0 2):S6-8. doi: 10.1002/ibd.20544.
5
Breast feeding.母乳喂养。
BMJ. 2008 Apr 19;336(7649):881-7. doi: 10.1136/bmj.39521.566296.BE.
6
Inflammatory bowel diseases: the paediatric gastroenterologist's perspective.炎症性肠病:儿科胃肠病学家的观点
Pediatr Radiol. 2007 Nov;37(11):1065-70. doi: 10.1007/s00247-007-0573-3. Epub 2007 Sep 25.
7
Unravelling the pathogenesis of inflammatory bowel disease.揭示炎症性肠病的发病机制。
Nature. 2007 Jul 26;448(7152):427-34. doi: 10.1038/nature06005.
8
Inflammatory bowel disease: clinical aspects and established and evolving therapies.炎症性肠病:临床特征及已确立和不断发展的治疗方法
Lancet. 2007 May 12;369(9573):1641-57. doi: 10.1016/S0140-6736(07)60751-X.
9
Inflammatory bowel disease: cause and immunobiology.炎症性肠病:病因与免疫生物学
Lancet. 2007 May 12;369(9573):1627-40. doi: 10.1016/S0140-6736(07)60750-8.
10
Characteristics of inflammatory bowel disease with onset during the first year of life.出生后第一年起病的炎症性肠病的特征
J Pediatr Gastroenterol Nutr. 2006 Nov;43(5):603-9. doi: 10.1097/01.mpg.0000237938.12674.e3.